Safety and Efficacy of Tofacitinib For Up to 9.5 Years in The Treatment of Rheumatoid Arthritis: Final Results of a Global, Open-Label, Long-Term Extension Study
Arthritis Res Ther. 2019 Apr 5;21(1):89.
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Arthritis Res Ther. 2019 Apr 5;21(1):89.
Immunotherapy. 2019 Mar;11(4):321-333.
J Clin Pharm Ther. 2019 Jun;44(3):384-396.
Ann Rheum Dis. 2019 Jun;78(6):849-850.
Arthritis Rheumatol. 2019 Jun;71(6):878-891
Semin Arthritis Rheum. 2018 Dec;48(3):406-415. doi: 10.1016/j.semarthrit.2018.07.006.
Desai RJ, et al. Arthritis Rheumatol. 2019 June;71(6):892-900.
Please click the links below to go to the CSF review of each paper
Arthritis Rheumatol 2018 DOI: 10. 1002/art.40780
Arthritis Care Res 2018 DOI 10.1002/acr.23769